Oral ketamine therapy in the treatment of postamputation stump pain

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 3, 1997, Pages 427-429

  Nikolajsen, L ^a   Hansen, P O ^a   Jensen, T S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ketamine; Mechanical stimuli; NMDA receptor; Stump pain; Thermal stimuli

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ADULT; AMPUTATION STUMP; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CASE REPORT; DRUG EFFICACY; HUMAN; MALE; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL;

EID: 0030937991     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04710.x     Document Type: Article

References (16)

1. Jensen TS, Rasmussen P. Phantom pain and other phenomena after amputation. In: Wall PD and Melzack R, eds. Textbook of pain. Edinburgh: Churchill Livingstone, 1994: 651-665.
2. Melsack R. Phantom limb pain: Implications for treatment of pathologic pain. Anesthesiology 1971: 35: 409-419.
3. Sherman RA, Sherman CJ, Gall NG. A survey of current phantom limb treatment in the United States. Pain 1980: 8: 85-99.
4. Bennett GJ. Animal models of neuropathic pain. In: Gebhart GF, Hammond DL, Jensen TS, eds. Proc. 7th World Congress on Pain. Seattle: IASP Press, 1994: 495-511.
5. Devor M, Rappaport HZ. Pain and the pathophysiology of damaged nerve. In: Wall PD, Melsack R, eds. Textbook of pain. Edingburgh: Churchill Livingstone, 1989: 47-83.
6. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993: 52: 259-285.
7. Stannard CF, Porter GE. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 1993: 54: 227-230.
8. Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994: 56: 51-57.
9. Eide PK, Jørum E, Stubhaug A, Bremnes J, Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994: 58: 347-354.
10. Eide PK, Stubhaug A, Øye I, Breivik H. Continous subcutaneous administration of the N-methyl-D-aspartate acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995: 61: 221-228.
11. Mathisen LC, Skjelbred P, Skoglund LA, Øye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 1995: 61: 215-220.
12. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. Effect of NMDA receptor antagonism with ketamine and magnesium chloride in chronic neuropathic pain. Pain 1995: 64: 283-291.
13. Hoffman V, Coppejans H, Vercauteren M, Adriaensen H. Succesful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994: 10: 240-242.
14. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg 1995: 81: 63-68.
15. Nyström B, Hagbarth KE. Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neuroscience Lett 1981: 27: 211-216.
16. Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt-Nielsen L, Jensen TS. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996: 67: 69-77.